Welcome to Knowledge Base!

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Categories
All

Products-AspenTech Pharma Suite

Empowering the Pharmaceutical Industry: GSK's Future-Ready Supply Chain with AspenTech Pharma Suite

Introduction to AspenTech Pharma Suite

GlaxoSmithKline (GSK) has successfully implemented Aspen Mtell® from AspenTech to bolster the resilience and reliability of their pharmaceutical supply chains. By leveraging predictive and prescriptive maintenance solutions offered by AspenTech, GSK has managed to proactively address potential issues, thus avoiding unplanned production downtime.

Key Benefits of Aspen Mtell for GSK

The implementation of Aspen Mtell has yielded significant results for GSK, including providing 35 days of advance warning for potential issues. This advanced warning system has enabled GSK to avert tens of millions of USD in lost batches, ensuring continuous production and supply chain efficiency. Additionally, GSK has experienced a remarkable 50% reduction in lifecycle maintenance costs, contributing to overall cost savings and operational efficiency. With 30 sites across 18 countries covered, GSK has maximized the value gained from AspenTech's innovative technology.

Future-Ready Supply Chain Empowerment

AspenTech's technology plays a pivotal role in empowering GSK to create a reliable and future-ready supply chain. By integrating predictive and prescriptive maintenance solutions, GSK has enhanced their operational agility, minimized production disruptions, and optimized asset performance. This strategic partnership between AspenTech and GSK underscores the importance of leveraging cutting-edge technology to navigate the evolving landscape of the pharmaceutical industry.

Seizing New Opportunities: AspenTech Pharma Suite's Roadmap for Smarter Manufacturing

Pharma Industry's Digital Transformation

The AspenTech Pharma Suite's report on the future of digital transformation and manufacturing in the pharmaceutical industry is based on a survey of 400 professionals in the US and Europe. The study also includes insights from industry leaders at GSK, Roche, Merck KGaA Darmstadt, Germany, and Kashiv BioSciences. Among the key topics covered in the report are the changing confidence levels of pharma manufacturers in digital transformation, the hurdles faced in leveraging technology for revenue growth while enhancing access to medicine, and the initiatives prioritized for smarter manufacturing.

Read article

Empowering Power Reliability with AspenTech Microgrid Management System

Optimizing Power Reliability and Efficiency

AspenTech Microgrid Management System™ (MMS) offers a comprehensive solution to deliver renewable power and manage on-site storage and cogeneration, ensuring optimized reliability, availability, and security of power for energy-critical assets and infrastructure. This system enables users to achieve uninterrupted power supply and operational continuity through balanced generation, demand, and storage. By leveraging a combination of renewables, power storage, virtual renewables (VPP), and grid power, businesses can align their operating OPEX and carbon neutrality objectives, minimize OPEX, and reduce their carbon footprint simultaneously.

Read article

Revolutionizing the Pharmaceutical Industry with AspenTech Pharma Suite

The Power of AspenTech Pharma Suite

AspenTech Pharma Suite is a cutting-edge solution designed to revolutionize and optimize pharmaceutical operations. This comprehensive suite of tools offers pharmaceutical companies a range of capabilities, from process optimization to supply chain management and regulatory compliance. The power of AspenTech Pharma Suite lies in its ability to streamline processes, improve efficiency, and ensure regulatory compliance at every step of the pharmaceutical production cycle.

Read article

Revolutionizing Pharma Manufacturing: AspenTech Pharma Suite's Roadmap to Smarter Operations

Challenges in Pharma Manufacturing Landscape

The pharmaceutical industry faces unprecedented challenges in today's complex landscape. From geopolitical tensions to disruptions in the supply chain caused by the pandemic, companies are under immense pressure to navigate these obstacles while meeting the growing demand for faster time-to-market solutions. A recent study by FT Longitude, involving insights from 400 experts in drug development and manufacturing, as well as professionals from renowned companies like GSK, Roche, Merck KGaA (Darmstadt Germany), and Kashiv BioSciences, sheds light on the future direction of drug manufacturing in the next 3-5 years.

Read article

Maximizing Decision-Making with Aspen Fidelis™ by AspenTech Pharma Suite

Unleashing the Power of Aspen Fidelis™

Aspen Fidelis™, a cutting-edge solution offered by AspenTech Pharma Suite, is designed to revolutionize decision-making processes within industrial settings. The platform serves as the first line of defense against unquantified risks to plant performance and revenue, providing invaluable insights that empower businesses to make informed choices. With Aspen Fidelis™, users can simulate diverse scenarios to gain a comprehensive understanding of how various factors impact operational efficiency and financial outcomes.

Read article